470 related articles for article (PubMed ID: 12615295)
1. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
Vaughan CJ
Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
3. [Statins and stroke].
Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
Miida T; Hirayama S; Nakamura Y
J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
6. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
Miida T; Takahashi A; Ikeuchi T
Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
[TBL] [Abstract][Full Text] [Related]
7. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
Mason RP; Walter MF; Day CA; Jacob RF
Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
[TBL] [Abstract][Full Text] [Related]
8. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
Vaughan CJ; Delanty N; Basson CT
CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
[TBL] [Abstract][Full Text] [Related]
9. Statins and stroke prevention.
Paciaroni M; Bogousslavsky J
Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
[TBL] [Abstract][Full Text] [Related]
10. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Igel M; Sudhop T; von Bergmann K
Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
[TBL] [Abstract][Full Text] [Related]
11. Statins and stroke.
Endres M
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1093-110. PubMed ID: 15815580
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of statins in the management of atherosclerosis.
Vaughan CJ; Gotto AM; Basson CT
J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the inflammatory process by statins.
Crisby M
Drugs Today (Barc); 2003 Feb; 39(2):137-43. PubMed ID: 12698208
[TBL] [Abstract][Full Text] [Related]
14. [Role of statins in prevention of stroke and dementia].
ten Dam VH; Bollen EL; Westendorp RG; Meinders AE; Blauw GJ
Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1918-21. PubMed ID: 11675972
[TBL] [Abstract][Full Text] [Related]
15. Statins in stroke: prevention, protection and recovery.
Switzer JA; Hess DC
Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299
[TBL] [Abstract][Full Text] [Related]
16. Statins and ischemic stroke.
Liao JK
Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
[TBL] [Abstract][Full Text] [Related]
17. Statins: the new aspirin?
Veillard NR; Mach F
Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy and stroke prevention.
Vaughan CJ; Delanty N; Basson CT
Curr Opin Cardiol; 2001 Jul; 16(4):219-24. PubMed ID: 11574782
[TBL] [Abstract][Full Text] [Related]
19. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the inflammatory process by statins.
Crisby M
Timely Top Med Cardiovasc Dis; 2005 Mar; 9():E3. PubMed ID: 15824762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
